News
Pfizer-Wyeth needn't derail Crucell deal: sources
By Ben Hirschler LONDON (Reuters) - Merger talks between Pfizer and Wyeth need not derail plans by Wyeth to buy Dutch vaccine maker Crucell, ...
Pfizer eyes Wyeth's drug pipeline
Pfizer probably has its eyes on Wyeth's Alzheimer's drug pipeline, he said. But he cautions that a merger won't be successful unless Wyeth's pipeline is ...
The Pfizer-Wyeth Deal Worst-Case Scenario
Look at the efficiency drive Pfizer has already been through and assume that the same could be repeated post-merger: Is a one-time $2 billion saving enough ...
Pictures
0 comments:
Post a Comment